“[Complementary Strategy of RSVpreF Vaccination Nirsevimab Versus Nirsevimab Alone for the Prevention of RSV Infection in Infants in Italy: A Cost-Minimization Analysis]”. 2025. Farmeconomia. Health Economics and Therapeutic Pathways 26 (1). https://doi.org/10.7175/fe.v26i1.1583.